Mustang Bio, Inc.
Mustang Bio, Inc. (MBIO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MBIO · as of Jun 9, 2026
Key Statistics
Explore Mustang Bio, Inc. Data
mbio stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 100.0%
Competitors & Peers
mbio competitorsMBIO
ABP
ACXP
BOLT
DWTX
EVGNStock Performance
Full HistoryAbout Mustang Bio, Inc.
Mustang Bio, Inc. is a clinical-stage biopharmaceutical firm dedicated to transforming groundbreaking advancements in cell and gene therapies into potential therapeutic options for hematological malig…
what is mustang bio, inc. · mbio stock overview · mustang bio, inc. company profile · who is mustang bio, inc. ceo · mbio NASDAQ · mustang bio, inc. headquarters · mustang bio, inc. business segments
About Stock Overview & Key Data
Mustang Bio, Inc. (MBIO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 22, 2017. As of the latest trading session, MBIO stock price is $0.70, with a market capitalization of $5.3M. The stock has returned -45.73% over the past 12 months and -28.63% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Mustang Bio, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Mustang Bio, Inc. reported revenue of — and net income of -$1.9M. For detailed data — including Mustang Bio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Mustang Bio, Inc. (MBIO) stock price is $0.70. The stock is traded on NASDAQ under the ticker symbol MBIO. The 52-week range is $0.53 – $7.00.